Navigation Links
Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego
Date:5/16/2013

SAN DIEGO, May 16, 2013 /PRNewswire/ -- The registration deadline has been extended until May 22 for the Association of Bioscience Financial Officers (ABFO) 2013 National Conference, the premier conference for bioscience financial officers. The conference will be held May 28-31 at the Hilton San Diego Bayfront.

"We are putting the finishing touches on this year's conference and want to make sure as many people as possible have the opportunity to attend," said Brandi Roberts , Chief Financial Officer of Mast Therapeutics, Inc. and the 2013 National Conference Chair.

More than 140 financial leaders from life sciences companies have already registered for the conference.  The theme for the 2013 National Conference is "Creating and Capturing Value in Bioscience." The conference includes keynote speakers and breakout sessions all with a focus on value beyond just the areas of finance and accounting, encompassing operational excellence, business development, regulatory expertise and team building.  

Through keynote addresses and breakout sessions, ABFO will welcome numerous speakers, including:

  • Michael Abrashoff , Former Navy Commander and Author
  • Brian Baker , VP of Finance, Cleave Biosciences
  • Robert Baltera , Former CEO, Amira Pharmaceuticals , Inc.
  • Daniel Bradbury , Former CEO, Amylin Pharmaceuticals, Inc.
  • David Conway , Sr. Director Clinical Operations, Halozyme Therapeutics
  • Brian Culley , CEO, Mast Therapeutics, Inc.
  • Karin Eastham , Board Member – MorphoSys AG, Trius Therapeutics, Illumina, Crosswalk Press LLC, Geron
  • Mark Foletta , Former CFO, Amylin Pharmaceuticals, Inc.
  • Alan Fuhrman ,Chief Financial Officer, Ambit
  • Koji Fukumura , Partner, Cooley LLP
  • Carol Gallagher , Former President and CEO of Calistoga Pharmaceuticals
  • Greg Guarasci , Sr. VP of Clinical Operations, PRA International
  • Hans-Peter Guler , Sr. VP Clinical Development, Endocrine & Cardiovascular, INC. Research
  • Faheem Hasnain , President and CEO, Receptos
  • Kent Hawryluk , CEO, Tall Ship Group, LLC
  • Robert Hoffman , Senior Vice President, Finance and CFO, Arena Pharmaceuticals
  • Gary A. Holden , Director of Information Technology, Vical Incorporated
  • Jason Kent , Partner, Cooley LLP
  • Moisha Platto , VP Proposals & Finance, PRA International
  • Dr. Stanley Rockson , Chief of Consultative Cardiology at Stanford University School of Medicine
  • Killu Sanborn , Oxford Finance
  • Tamara A. Seymour , CFO, HemaQuest Pharmaceuticals, Inc.
  • Armen B. Shanafelt , Ph.D., Venture Partner, Lilly Ventures
  • Larry Smith , FASB Member
  • Phil Schneider , Former CFO, IDEC Pharmaceuticals
  • Lisa Thompson , Associate Director of Lean Enterprise Center of Excellence, Hologic | Gen-Probe
  • Will Waddell , Sr. Vice President, Chief Financial Officer, OncoMed Pharmaceuticals, Inc.
  • Robert Williamson , Founder, LaSalle Venture Advisers, Former Director, Pharmasset
  • Troy Wilson , President and CEO, Wellspring Biosciences LLC
  • Jerry Wright , Senior Vice President of Lean and Enterprise Excellence, DJO Global

Registration can be completed online at www.abfointernational.org/conference through May 22, 2013.  The cost to attend the conference is $1,300, and up to 18 hours of continuing education credits are available.  For more information about the conference, contact Brandi Roberts at broberts@mastthera.com.

Sponsors of the event include AON, Bank of America Merrill Lynch, Brinson Patrick , Ernst & Young, Oxford Finance and Cooley LLP.  The conference is also supported by Russo Partners, PR Newswire and BioCentury.

About the Association of Bioscience Financial Officers

Formed in 1989, the Association of Bioscience Financial Officers has eleven chapters that serve as forums for the exchange of information about the industry and networking. Regional chapters are based in top bioscience concentrations to allow for face-to-face meetings and discussion of hot topics of interest to bioscience financial officers. The regional chapters meet annually for the ABFO National Conference for extended networking. For more information, visit www.abfointernational.org.

Media Contact: 
Ian Stone or Monica May 
Russo Partners 
(619) 308-6541  
(619) 308-6542 
ian.stone@russopartnersllc.com 
monica.may@russopartnersllc.com


'/>"/>
SOURCE Association of Bioscience Financial Officers
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
2. Registration Now Open for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego
3. Marrone Bio Innovations Submits New Bioherbicide for EPA Registration
4. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
5. Bayer CropScience Announces Registration for use of Alion on Grapes in California
6. Regulus Files Registration Statement for Proposed Initial Public Offering
7. National Defense Industrial Association (NDIA) Opens Registration For 2012 Biosurveillance Conference, Set For August 27-28 in Washington, D.C.
8. Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration
9. Registration now open: 2012 Regional, State, and Local Initiatives in Nanotechnology
10. ETEX Corporation announces extended Supply Agreement with Knee Creations, LLC
11. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Book Titles Until the End of March at Chemical Publishing Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 Kineta, Inc., a biotechnology ... therapies in immuno-oncology, today announced the discovery and ... compounds that activate interferon response factor 3 (IRF3) ... immune-mediated tumor regression in a murine colon carcinoma ... demonstrated complete tumor regression to initial drug treatment ...
(Date:3/23/2017)... , March 23, 2017 According to ... products and derivatives market is fragmented due to the presence of a ... as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each ... three companies, collectively, held more than 76% of this market in ... As of ...
(Date:3/23/2017)... , March 23, 2017 In ... four equities in the Biotech industry: Sangamo Therapeutics Inc. ... Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from ... their free report at: ...
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
Breaking Biology Technology:
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:3/1/2017)... 2017  Aware, Inc. (NASDAQ: AWRE), a leading supplier ... P. Moberg has resigned, effective March 3, 2017, ... Officer and Treasurer of Aware citing a desire to ... member of the Board of Directors of Aware. ... Officer and co-President, General Counsel has been named Chief ...
(Date:2/28/2017)... Februar 2017  EyeLock LLC, ein marktführendes Unternehmen im ... biometrische Lösung zur Iris-Erkennung auf der neuesten ... auf dem Mobile World Congress 2017 (27. ... Halle 3, Stand 3E10, vorstellen. ... Haven™ – eine Kombination aus Hardware, Software ...
Breaking Biology News(10 mins):